Inventors: Kumar Pranav Narayan, Rajkumar Banerjee

The study investigates a glucocorticoid receptor (GR)-targeted liposomal nano-platform designed to enhance drug sensitivity and reverse epithelial-to-mesenchymal transition (EMT) in aggressive oral cancer. The nano-platform uses liposomes—small lipid-based carriers—to deliver therapeutic agents specifically to cells expressing GR, a receptor often involved in cancer progression and drug resistance.